# TELO (Telomir Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Telomir Pharmaceuticals, Inc. reported $4.64M in total assets and a net loss of $5.48M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TELO
- Markdown: https://convexityos.com/fundamentals/TELO.md
- SEC CIK: 0001971532
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001971532&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | -$5.48M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.08 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $4.52M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $2.44M | $2.24M | $1.57M | $833K |
| Total Operating Expenses | $10.54M | $12.24M | $3.94M | $854K |
| Interest Income | $126K | $48K | -- | -- |
| Interest Expense | -- | $4.34M | $1.64M | -- |
| **Net Income** | -$10.41M | -$16.53M | -$13.07M | -$854K |
| Basic EPS | -$0.33 | -$0.56 | $0.48 | -$0.03 |
| **Diluted EPS** | -$0.33 | -$0.56 | $0.48 | -$0.03 |
| Basic Shares Outstanding | 31.7M | 29.5M | 27.3M | 26.8M |
| Diluted Shares Outstanding | 31.7M | 29.5M | 27.3M | 26.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $252K | $445K | $468K | $1.30M | $760K | $43K | $337K | $269K |
| Total Operating Expenses | $745K | $1.76M | $1.04M | $2.13M | $1.15M | $5.07M | $2.19M | $2.91M |
| **Operating Income** | -- | -- | -- | -- | -- | -- | $2.19M | -- |
| Interest Income | $42K | $46K | $52K | $72K | $44K | $1.4K | $8.0K | -- |
| Interest Expense | $1.9K | $3.0K | $1.3K | -- | $0 | $1.3K | $46 | -- |
| **Net Income** | -$705K | -$1.72M | -$991K | -$2.06M | -$1.10M | -$5.07M | -$2.18M | -$2.90M |
| Basic EPS | -$0.01 | -$0.79 | -$0.03 | -- | -$0.03 | -$0.17 | -$0.07 | -- |
| **Diluted EPS** | -$0.01 | -$0.79 | -$0.03 | -- | -$0.03 | -$0.17 | -$0.07 | -- |
| Basic Shares Outstanding | 68.8M | 60.8M | 34.4M | -- | 32.4M | 30.0M | 29.8M | -- |
| Diluted Shares Outstanding | 68.8M | 60.8M | 34.4M | -- | 32.4M | 30.0M | 29.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.29M | $1.27M | $1.2K | $1.4K |
| **Cash & Short-Term Investments** | $7.29M | $1.27M | $1.2K | $1.4K |
| **Total Current Assets** | $7.34M | $1.32M | $435K | $49K |
| **Total Non-Current Assets** | $0 | $0 | $4.34M | $0 |
| **Total Assets** | $7.34M | $1.32M | $4.77M | $49K |
| Accounts Payable | -- | -- | $475K | -- |
| Other Current Liabilities | $318K | $93K | $527K | -- |
| **Total Current Liabilities** | $1.43M | $681K | $1.34M | $986K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $1.43M | $681K | $1.34M | $986K |
| Retained Earnings | -$41.01M | -$30.60M | -$14.06M | -$992K |
| **Total Stockholders' Equity** | $5.91M | $643K | $3.44M | -$937K |
| Total Equity | $5.91M | $643K | $3.44M | -$937K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.52M | $5.17M | $5.56M | $7.29M | $7.33M | $754K | $403K | $1.27M |
| **Cash & Short-Term Investments** | $4.52M | $5.17M | $5.56M | $7.29M | $7.33M | $754K | $403K | $1.27M |
| **Total Current Assets** | $4.64M | $5.37M | $5.79M | $7.34M | $7.40M | $830K | $491K | $1.32M |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $4.64M | $5.37M | $5.79M | $7.34M | $7.40M | $830K | $491K | $1.32M |
| Other Current Liabilities | -- | -- | $345K | $318K | $93K | $93K | $93K | $93K |
| **Total Current Liabilities** | $237K | $332K | $827K | $1.43M | $423K | $348K | $652K | $681K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $237K | $332K | $827K | $1.43M | $423K | $348K | $652K | $681K |
| Retained Earnings | -$44.43M | -$43.72M | -$42.00M | -$41.01M | -$38.95M | -$37.85M | -$32.78M | -$30.60M |
| **Total Stockholders' Equity** | $4.40M | $5.03M | $4.96M | $5.91M | $6.98M | $481K | -$161K | $643K |
| Total Equity | $4.40M | $5.03M | $4.96M | $5.91M | $6.98M | $481K | -$161K | $643K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$10.41M | -$16.53M | -$13.07M | -$854K |
| Stock-Based Compensation | $5.29M | $6.87M | -- | -- |
| **Operating Cash Flow** | -$3.69M | -$5.07M | -$3.86M | -$469K |
| Common Stock Issued | $9.60M | $6.83M | $1.00M | -- |
| **Financing Cash Flow** | $9.71M | $6.34M | $3.86M | $470K |
| **Net Change in Cash** | $6.02M | $1.26M | -$188 | $1.4K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$705K | -$1.72M | -$991K | -$2.06M | -$1.10M | -$5.07M | -$2.18M | -$2.90M |
| Stock-Based Compensation | $65K | $199K | $40K | -$7.9K | -$742K | $4.66M | $1.38M | -- |
| **Operating Cash Flow** | -$586K | -$1.01M | -$1.77M | -$1.20M | -$927K | -$696K | -$863K | -$606K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $1.00M |
| **Financing Cash Flow** | -$68K | $622K | $47K | -- | -- | -- | -- | $1.04M |
| **Net Change in Cash** | -$655K | -$390K | -$1.73M | -$43K | $6.57M | $351K | -$863K | $431K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -176.1% | -2571.0% | -380.2% | -- |
| Return on Assets (ROA) | -141.8% | -1248.7% | -273.8% | -1752.8% |
| Current Ratio | 5.14x | 1.94x | 0.33x | 0.05x |
| Quick Ratio | 5.10x | 1.86x | 0.00x | 0.00x |
| EPS Growth (YoY) | -- | -216.7% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -124.4% | -116.7% | -185.9% | -176.1% | -161.2% | -3353.7% | -- | -2571.0% |
| Return on Assets (ROA) | -118.0% | -109.5% | -159.3% | -141.8% | -152.0% | -1945.3% | -2536.3% | -1248.7% |
| Current Ratio | 19.60x | 16.14x | 7.00x | 5.14x | 17.51x | 2.38x | 0.75x | 1.94x |
| Quick Ratio | 19.07x | 15.55x | 6.72x | 5.10x | 17.33x | 2.17x | 0.62x | 1.86x |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | +14.2% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -440.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
